Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-β-CD-TEA inclusion complex

European Journal of Medicinal Chemistry

Volumn 43, Issue 3, 2008, Pages 464-470

  Granero, Gladys E ^a   Maitre, Marcos M ^a   Garnero, Claudia ^a   Longhi, Marcela R ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Acetazolamide; Cyclodextrins; In vitro release studies; Topical preparation; Triethanolamine

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETAZOLAMIDE; TRIETHANOLAMINE;

ARTICLE; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY;

ABSORPTION; ACETAZOLAMIDE; BETA-CYCLODEXTRINS; DRUG DESIGN; ETHANOLAMINES; INTRAOCULAR PRESSURE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 40049084598     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.03.037     Document Type: Article

References (26)

1. Kaur I.P., Smitha R., Aggarwal D., and Kapil M. Acetazolamide: future prespective in topical glaucoma therapeutics. Int. J. Pharm. 248 (2002) 1-14
2. Duffel M.W., Ing I.S., Segarra T.M., Dixson J.A., Barfkenecht C.F., and Schoenwald R.D. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure. J. Med. Chem. 29 (1986) 1488-1494
3. Maus T.L., Larsson L.I., McLaren J.W., and Brubaker R.F. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch. Ophthalmol. 115 (1997) 45-49
4. Loftsson T., Fridriksdottir H., Thorisdottir S., Stefansson E., and Sigthorsson T. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulation in rabbits. J. Pharm. Pharmacol. 46 (1994) 503-504
5. El-Gazayerly O.N., and Hikal A.H. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int. J. Pharm. 158 (1997) 121-127
6. Kaur I.P., Singh M., and Kanwar M. Formulation and evaluation of ophthalmic preparation of acetazolamide. Int. J. Pharm. 199 (2000) 119-127
7. Parasrampuria J., and Gupta V.D. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability. J. Pharm. Sci. 78 (1989) 855-857
8. Khamis E.F., Abdel-Hamid M., Hassan E.M., Eshra A., and Elsayed M.A. A stability-indicating first-derivative spectrophotometric assay of acetazolamide and its use in dissolution of kinetic studies. J. Clin. Pharm. Ther. 18 (1993) 97-101
9. Pitha J., Milecki J., Fales H., Pannell L., and Vekama K. HP-β-CD: preparation and characterization; effects on solubility of drugs. Int. J. Pharm. 29 (1986) 73-82
10. Loftsson T., Brewster M.E., Derendorf H., and Bodor N. 2-Hydroxypropyl-β-cyclodextrins: properties and usage in pharmaceutical formulations. Pharm. Ztg. Wiss 136 (1991) 5-10
11. J. Szejtli, Cyclodextrin Technology, Kluwer Academic Publishers, Boston, Dordrecht and The Netherlands, vol. 39, 1988, pp. 188-192.
12. Loftsson T., Olafsdottir B.J., and Bodor N. The effects of cyclodextrins on transdermal delivery of drugs. Eur. J. Pharm. Biopharm. 37 (1991) 30-33
13. Kristinsson J.K., Fridriksdottir H., Thorisdottir S., Sigurdardottir A.M., Stefansson E., and Loftsson T. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1199-1203
14. Redenti E., Szente L., and Szejtli J. Drug-cyclodextrin-hydroxy acid multicomponent systems: properties and pharmaceutical applications. J. Pharm. Sci. 89 (2000) 1-8
15. Redenti E., Szente L., and Szejtli J. Cyclodextrin complexes of salts of acidic drugs: thermodynamic properties, structural features, and pharmaceutical applications. J. Pharm. Sci. 90 (2001) 979-986
16. 1H NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with β-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 23 (2000) 25-31
17. Granero G., Garnero C., and Longhi M. The effect of a basic substance and pH on cyclodextrin complexation of sulfisoxazole. Eur. J. Pharm. Sci. 20 (2003) 285-293
18. Funk O., Schwabe L., and Fromming K. Freeze-dried preparations of ketoprofen and heptakis-(2,6-dimethyl)-ß-cyclodextrin. Drug Dev. Ind. Pharm. 20 (1994) 1957-1969
19. Fang L., Numajiri S., Kobayashi D., Ueda H., Nakayama K., Miyamae H., and Morimoto Y. Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. J. Pharm. Sci. 93 (2004) 144-154
20. In: Frömming K.H., and Szejtli J. (Eds). Cyclodextrin in Pharmacy (1994), Kluwer Academic Publisher, Dordrecht
21. Cohen S., Lobel E., Trevgoda A., and Peled Y. A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. J. Control. Release 44 (1997) 201-208
22. Higuchi T., and Connors K. Phase solubility techniques. In: Reilly C. (Ed). Advances in Analytical Chemistry and Instrumentation (1965), Wiley/Interscience, New York 117-212
23. Chufán E.E., Pedregosa J.C., Ferrer S., and Borrás J. Spectroscopic behavior of metal drug complexes. Infrared spectra of Cu(II) dimer complexes with acetazolamide (H2acm) and an analogue sulfonamide (B-H2ats). Vib. Spectrosc. 20 (1999) 35-45
24. Parasrampuria J. Acetazolamide. In: Britain H.G. (Ed). Analytical Profiles of Drug Substances and Excipients vol. 22 (1993), Academic Press, New York 1
25. Riegelman E., and Sorby D.L. EENT preparations. In: Martin E.W. (Ed). Husa's Pharmaceutical Dispensing. sixth ed. (1966), Mack Publishing Co, Easton, PA 311
26. Doughty M.J. Assessment of the effects of cetylpyridinium chloride on water content of the collagen-keratocyte matrix of the mammalian corneal stroma ex vivo. Biochim. Biophys. Acta 1426 (1999) 449-458